eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
SCImago Journal & Country Rank

Interview with Professor Janusz Skowronek
ABS 2015
vol. 10
Original paper

Clinical and dosimetric consequences of imperfect applicator insertion in cervical cancer brachytherapy

Bikramjit Chakrabarti, Suparna Kanti Pal, Harris Mahammad Sepai, Somapriya Basu-Roy, Sanjay Kumar Kar, Annesha Lahiri, Sounik Das, Amit Bala

J Contemp Brachytherapy 2018; 10, 4: 321–336
Online publish date: 2018/08/31
View full text
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
This study analyzes clinical consequences and dosimetric variations after imperfect brachytherapy insertions. It examines treatment decisions after such insertions in patients having difficult anatomy, which leads to good subsequent insertions with acceptable dose volume parameters.

Material and methods
We reviewed images of all insertions performed during last one year and sorted faulty ones out. Clinical outcome was assessed, analyzing original treatment records. Repeat three-dimensional planning using identical dose-optimization-technique compared their dosimetry. Statistical analysis using SPSS®-Statistics-software included Fisher’s-exact-test to analyze predisposing factors for faulty insertions and predictive factors for subsequent satisfactory insertion. Friedman test was used to compare dose-volume-effects of normalization.

Eighteen of 292 brachytherapy plans revealed imperfect insertions, including thirteen perforations (4.5%). Lack of pre-planning, obstructing mass, narrow vagina, acute anteversion of uterus, and multi-parity were significant (p ≤ 0.05) predisposing factors for atypical insertions. Satisfactory optimization was possible after correcting acute anteflexion or positioning tandem in retroverted direction in uncorrectable retroverted uterus. Dose normalization at point A shifted optimized dose from contoured volume to point of normalization, often undesirably. This difference, however, was statistically not significant (p = 0.121). In patients having obstructing mass, subsequent insertions were perfect, and dose volume parameters were acceptable only when full prescribed dose was delivered to at least 60% volume of the mass after a faulty insertion (p < 0.001).

Pre-planning by imaging is suggested in all cases of brachytherapy. Insertion of adequate length of tandem aligned to uterine axis is warranted for adequate tumor coverage. Whenever detected, acute anteflexion and mobile retroversion should be corrected. Tandem inserted in retroverted direction in uncorrectable retroverted uterus generates acceptable dose volume parameters. In cases with obstructive cervical mass, good subsequent insertion is possible with acceptable dose volume parameters, if planned dose can be delivered to its 60% volume.


applicator, brachytherapy, cervical cancer, difficult, dose-volume, guidelines, problem, insertion

Mongula J, Slangen B, Lambregts D et al. Predictive criteria for MRI-based evaluation of response both during and after radiotherapy for cervical cancer. J Contemp Brachytherapy 2016; 8: 183-190.
Villalba SR, Sancho JR, Palacín AO et al. Development and clinical implementation of a new template for MRI-based intracavitary/interstitial gynecologic brachytherapy for locally advanced cervical cancer: from CT-based MUPIT to the MRI compatible Template Benidorm. Ten years of experience. J Contemp Brachytherapy 2016; 8: 404-414.
Siavashpour Z, Aghamiri MR, Jaberi R et al. Optimum organ volume ranges for organs at risk dose in cervical cancer intracavitary brachytherapy. J Contemp Brachytherapy 2016; 8: 135-142.
Basu B, Basu S, Chakraborti B et al. A comparison of dose distribution from Manchester-style and Fletcher-style intracavitary brachytherapy applicator systems in cervical cancer. J Contemp Brachytherapy 2012; 4: 213-218.
Chakrabarti B, Basu-Roy S, Kar S et al. Comparison of dose volume parameters evaluated using three forward planning – optimization techniques in cervical cancer brachytherapy involving two applicators. J Contemp Brachytherapy 2017; 9: 431-445.
Wang X, Li J, Wang P et al. Image-guided radiation therapy boost in combination with high-dose-rate intracavitary brachytherapy for the treatment of cervical cancer. J Contemp Brachytherapy 2016; 8: 122-127.
Otter S, Franklin A, Ajaz M et al. Improving the efficiency of image-guided brachytherapy in cervical cancer. J Contemp Brachytherapy 2016; 8: 557-565.
Corn BW, Hanlon AL, Pazak TF et al. Technically accurate intracavitary insertions improve pelvic control and survival among patients with locally advanced carcinoma of uterine cervix. Gynecol Oncol 1994; 53: 294-300.
American Brachytherapy Society cervical cancer brachytherapy task group. Viswanathan AN, Thomadsen B. Available at: https://www.americanbrachytherapy.org/guidelines/cervical_cancer_taskgroup.pdf (Accessed: 20 October 2017).
Suneja G, Brown D, Chang A et al. American Brachytherapy Society: Brachytherapy treatment recommendations for locally advanced cervix cancer for low-income and middle-income countries. Brachytherapy 2017; 16: 85-94.
Viswanathan AN, Beriwal S, Viswanathan JD. The American Brachytherapy Society Treatment Recommendations for Locally Advanced Carcinoma of the Cervix Part II: High Dose-Rate Brachytherapy. Brachytherapy 2012; 11: 47-52.
Pötter R, Haie-Mederb C, Limbergenc EV et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006; 78: 67-77.
Uterine perforation during gynecologic procedures. Barbara S Levy. Available at https://www.uptodate.com/contents/uterine-perforation-during-gynecologic-procedures (Accessed: 20 October 2017).
Prabhakar GS, Revannasiddaiah S, Susheela SP et al. Uterine perforation during intracavitary brachytherapy for carcinoma of the cervix. BMJ Case Rep 2012. doi:10.1136/bcr-2012-007830.
Irvin W, Rice L, Taylor P et al. Uterine perforation at the time of brachytherapy for carcinoma of the cervix. Gynecol Oncol 2003; 90: 113-122.
Barnes EA, Thomas G, Ackerman I et al. Prospective comparison of clinical and computed tomography assessment in detecting uterine perforation with intracavitary brachytherapy for carcinoma of the cervix. Int J Gynecol Cancer 2007; 17: 821-826.
Small W Jr, Strauss JB, Hwang CS et al. Should uterine tandem applicators ever be placed without ultrasound guidance? No: a brief report and review of the literature. Int J Gynecol Cancer 2011; 21: 941-944.
Onal C, Guler OC, Dolek Y et al. Uterine perforation during 3-dimensional image-guided brachytherapy in patients with cervical cancer: Baskent University experience. Int J Gynecol Cancer 2014; 24: 346-351.
Jhingran A, Eifel PJ. Perioperative and postoperative complications of intracavitary radiation for FIGO stage I–III carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000; 46: 1177-1183.
Corn BW, Shaktman BD, Lanciano RM et al. Intra- and peri­operative complications associated with tandem and colpostat application for cervix cancer. Gynecol Oncol 1997; 64: 224-229.
Kim RY, Levy DS, Brascho DJ et al. Uterine perforation during intracavitary application. Radiology 1983; 147: 249-251.
Rotmensch J, Waggoner SE, Quiet C. Ultrasound guidance for placement of difficult intracavitary implants. Gynecol Oncol 1994; 54: 159-162.
Perforation with uterine sound and suction cannula during D&C. Eugene C. Toy. Available at: https://exxcellence.org/perals-of-exxcellence/list-of-pearls/perforation-with-uterine-sound (Accessed 20 October 2017).
Makin WP, Hunter RD. CT scanning in intracavitary therapy: unexpected findings in “straightforward” insertions. Radiother Oncol 1988; 13: 253-255.
Rao PB, Ghosh S. Routine use of ultrasound guided tandem placement in intracavitary brachytherapy for the treatment of cervical cancer – a South Indian institutional experience. J Contemp Brachytherapy 2015; 7: 352-356.
Akbas T, Ugurluer G, Acil M et al. Intraoperative sonographic guidance for intracavitary brachytherapy of cervical cancer. J Clin Ultrasound 2018; 46: 8-13.
Schaner PE, Caudell JJ, De Los Santos JF et al. Intraoperative ultrasound guidance during intracavitary brachytherapy applicator placement in cervical cancer: The University of Alabama at Birmingham experience. Int J Gynecol Cancer 2013; 23: 559-566.
Davidson MT, Yuen J, D’Souza DP et al. Optimization of high-dose-rate cervix brachytherapy applicator placement: the benefits of intraoperative ultrasound guidance. Brachytherapy 2008; 7: 248-253.
Mayr NA, Montebello JF, Sorosky JI et al. Brachytherapy management of the retroverted uterus using ultrasound-guided implant applicator placement. Brachytherapy 2005; 4: 24-29.
Lim MC, Jung DC, Kim JY et al. Laparoscopy-assisted intracavitary radiotherapy tandem placement for patients with cervical cancer. Int J Gynecol Cancer 2009; 19: 1125-1130.
Viswanathan AN, Moughan J, Small W et al. The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128. Int J Gynecol Cancer 2012; 22: 123-131.
Bahadur YA, Eltaher MM, Hassouna AH et al. Uterine perforation and its dosimetric implications in cervical cancer high-dose-rate brachytherapy. J Contemp Brachytherapy 2015; 7: 41-47.
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe